Bo Wang
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Generation of therapeutic T cells from human induced pluripotent stem cells.
Journal: Inflammation and regeneration
Published: February 25, 2026
Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine.
Journal: Cell stem cell
Published: October 21, 2025
Adaptive-like CAR-iPSC-CD4⁺ T cells outperform CD8⁺ counterparts in sustained ALL control.
Journal: Inflammation and regeneration
Published: October 05, 2025
Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin.
Journal: Regenerative therapy
Published: October 15, 2024
Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system.
Journal: Regenerative therapy
Published: January 17, 2024
Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.
Journal: Biochemical and biophysical research communications
Published: April 12, 2023
Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.
Journal: Molecular therapy. Methods & clinical development
Published: July 08, 2022
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.
Journal: Nature biomedical engineering
Published: December 21, 2021
Capturing human trophoblast development with naive pluripotent stem cells in vitro.
Journal: Cell stem cell
Published: September 25, 2020
Last Updated: 09/26/2026